Cargando…

A Novel Humanized Model of NASH and Its Treatment With META4, A Potent Agonist of MET

BACKGROUND & AIMS: Nonalcoholic fatty liver disease is a frequent cause of hepatic dysfunction and is now a global epidemic. This ailment can progress to an advanced form called nonalcoholic steatohepatitis (NASH) and end-stage liver disease. Currently, the molecular basis of NASH pathogenesis i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jihong, Tan, Xinping, Kwon, Yongkook, Delgado, Evan R., Zarnegar, Arman, DeFrances, Marie C., Duncan, Andrew W., Zarnegar, Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688725/ https://www.ncbi.nlm.nih.gov/pubmed/34756982 http://dx.doi.org/10.1016/j.jcmgh.2021.10.007

Ejemplares similares

A Hepatocyte Growth Factor Receptor (Met)–Insulin Receptor hybrid governs hepatic glucose metabolism
por: Fafalios, Arlee, et al.
Publicado: (2011)

Pathomechanisms in central serous chorioretinopathy: A recent update
por: Zarnegar, Arman, et al.
Publicado: (2023)

Advances in Optical Coherence Tomography Imaging Technology and Techniques for Choroidal and Retinal Disorders
por: Ong, Joshua, et al.
Publicado: (2022)

Large central lumbar disc herniation causing acute cauda equina syndrome with loss of evoked potentials during prone positioning for surgery
por: Ammar, Adam, et al.
Publicado: (2018)

Association of the +49 A/G Polymorphism of CTLA4 Gene with Idiopathic Recurrent Spontaneous Abortion in Women in Southwest of Iran
por: Rasti, Zarnegar, et al.
Publicado: (2016)

Fe(3)O(4)/SO(3)H@zeolite-Y as a novel multi-functional and magnetic nanocatalyst for clean and soft synthesis of imidazole and perimidine derivatives
por: Kalhor, Mehdi, et al.
Publicado: (2019)

The IL-6 -634C/G polymorphism: a candidate genetic marker for the prediction of idiopathic recurrent pregnancy loss
por: Rasti, Zarnegar, et al.
Publicado: (2016)

Innate Immunity Induces the Accumulation of Lung Mast Cells During Influenza Infection
por: Zarnegar, Behdad, et al.
Publicado: (2018)

Combining Circumvestibular Corticotomy with Maxillary Protraction as a Conservative Approach to Treatment in an Adolescent with Maxillary Deficiency: A Case Report with Long Term Follow-up
por: Piroozmand, Farzad, et al.
Publicado: (2022)

Local Nash Equilibrium in Social Networks
por: Zhang, Yichao, et al.
Publicado: (2014)

Hiatal Hernia Presenting with Recurrent Non‐ST Elevation Myocardial Infarction and Cardiac Tamponade
por: Arvind, Ashwini, et al.
Publicado: (2019)

Targeted chromatin ligation, a robust epigenetic profiling technique for small cell numbers
por: Zarnegar, Mark A., et al.
Publicado: (2017)

Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
por: Griffett, Kristine, et al.
Publicado: (2023)

Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonist
por: de Nola, Giovanni, et al.
Publicado: (2022)

Mefloquine, an anti-malaria agent, causes reactive oxygen species-dependent cell death in mast cells via a secretory granule-mediated pathway
por: Paivandy, Aida, et al.
Publicado: (2014)

c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types
por: Drescher, Hannah K., et al.
Publicado: (2018)

Ablation therapy using a low dose of radioiodine may be sufficient in low- to intermediate-risk patients with follicular variant papillary thyroid carcinoma
por: Li, Fuxin, et al.
Publicado: (2020)

Clinical Response to PI3K-α Inhibition in a Cohort of Children and Adults With PIK3CA-Related Overgrowth Spectrum Disorders
por: Raghavendran, Prashant, et al.
Publicado: (2022)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

Artificial human Met agonists based on macrocycle scaffolds
por: Ito, Kenichiro, et al.
Publicado: (2015)

Nash vek /
por: Nappelʹbaum, Moisei Solomonovich, 1869-1958
Publicado: (1984)

Nash manifolds
por: Shiota, Masahiro
Publicado: (1987)

Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective
por: Finnerty, Brendan M, et al.
Publicado: (2017)

Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist
por: Simonneau, Claire, et al.
Publicado: (2015)

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021)

Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis
por: Hayashi, Momoko, et al.
Publicado: (2023)

Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations
por: Li, Pengyun, et al.
Publicado: (2023)

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
por: Jain, Mukul R., et al.
Publicado: (2017)

Influenza Infection in Mice Induces Accumulation of Lung Mast Cells through the Recruitment and Maturation of Mast Cell Progenitors
por: Zarnegar, Behdad, et al.
Publicado: (2017)

SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivo
por: Pettersson, Hanna, et al.
Publicado: (2017)

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH
por: Ramadori, Pierluigi, et al.
Publicado: (2017)

Renoprotective effects of a novel cMet agonistic antibody on kidney fibrosis
por: Kim, Yong Chul, et al.
Publicado: (2019)

Multiple malignant transformations of an ovarian mature cystic teratoma
por: Cagino, Kristen, et al.
Publicado: (2020)

The essential John Nash
por: Nash, John, et al.
Publicado: (2002)

Molecular Pathogenesis of NASH
por: Caligiuri, Alessandra, et al.
Publicado: (2016)

Natural history of NASH
por: Armandi, Angelo, et al.
Publicado: (2021)

Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
por: Sandoval‐Rodriguez, Ana, et al.
Publicado: (2020)

The Regenerative Effects of c-Met Agonistic Antibodies in Vocal Fold Atrophy
por: Choi, Hyunsu, et al.
Publicado: (2022)

A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH
por: Takayama, Fusako, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dbildoqvpoca8mthrkvab23d1j